Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol as a possible oxygen-sparing agent during exercise in peripheral arterial disease
2010-020662-23Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of allopurinol in arteriosclerosis obliterans, sponsored by University of Dundee. Primary endpoints: Distance to onset of claudication pain and Total exercise distance. Started Jul 2010; status: completed.
02
Drugs
allopurinol
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on 2010-020662-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020662-23.